Theravance Biopharma (TBPH) Earnings Date, Estimates & Call Transcripts $9.79 +0.29 (+3.05%) As of 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Feb. 26) -$0.05 Actual EPS (Feb. 26) -$0.31 Missed By -$0.26 Actual Revenue (Feb. 26) $18.75MTheravance Biopharma announced Q4 2024 earnings on February 26, 2025, reporting an EPS of -$0.31, which missed the consensus estimate of -$0.05 by $0.26. Quarterly revenue was reported to be $18.75 million, below analysts' expectations of $29.90 million. With a trailing EPS of -$1.15, Theravance Biopharma's earnings are expected to grow next year, from ($1.09) to $0.35 per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K) Slide DeckTBPH Upcoming EarningsTheravance Biopharma's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Theravance Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Theravance Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTBPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TBPH Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Theravance Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.43-$0.43-$0.43Q2 20251-$0.41-$0.41-$0.41Q3 20251-$0.29-$0.29-$0.29Q4 20251$0.88$0.88$0.88FY 20254-$0.25-$0.25-$0.25Q1 20261-$0.50-$0.50-$0.50Q2 20261-$0.50-$0.50-$0.50Q3 20261-$0.33-$0.33-$0.33Q4 20261$0.19$0.19$0.19FY 20264-$1.14-$1.14-$1.14Q1 20271-$0.40-$0.40-$0.40 Theravance Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/26/2025Q4 2024-$0.05-$0.31 -$0.26-$0.31$29.90M$18.75M11/12/2024Q3 2024-$0.1030-$0.26 -$0.1570-$0.26$16.11M$16.87M8/5/2024Q2 2024-$0.09-$0.34 -$0.25-$0.34$15.81M$14.26M5/13/2024Q1 2024-$0.28-$0.24+$0.04-$0.24$14.54M$14.50M2/26/2024Q4 2023-$0.15-$0.17 -$0.02-$0.17$17.49M$17.57M11/7/2023Q3 2023-$0.21-$0.17+$0.04-$0.17$15.59M$15.69M8/7/2023Q2 2023-$0.22-$0.28 -$0.06-$0.28$15.24M$13.75M5/8/2023Q1 2023-$0.27-$0.32 -$0.05-$0.29$13.82M$10.42M Theravance Biopharma Earnings - Frequently Asked Questions When is Theravance Biopharma's earnings date? Theravance Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on TBPH's earnings history. Did Theravance Biopharma beat their earnings estimates last quarter? In the previous quarter, Theravance Biopharma (NASDAQ:TBPH) missed the analysts' consensus estimate of ($0.05) by $0.26 with a reported earnings per share (EPS) of ($0.31). Learn more on analysts' earnings estimate vs. TBPH's actual earnings. How can I listen to Theravance Biopharma's earnings conference call? The conference call for Theravance Biopharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Theravance Biopharma's conference call transcript? The conference call transcript for Theravance Biopharma's latest earnings report can be read online. Read Transcript How much revenue does Theravance Biopharma generate each year? Theravance Biopharma (NASDAQ:TBPH) has a recorded annual revenue of $64.38 million. How much profit does Theravance Biopharma generate each year? Theravance Biopharma (NASDAQ:TBPH) has a recorded net income of -$55.19 million. TBPH has generated -$1.15 earnings per share over the last four quarters. What is Theravance Biopharma's EPS forecast for next year? Theravance Biopharma's earnings are expected to grow from ($1.09) per share to $0.35 per share in the next year. More Earnings Resources from MarketBeat Related Companies NAMS Earnings BLTE Earnings BHC Earnings JANX Earnings SUPN Earnings ARWR Earnings HRMY Earnings GLPG Earnings CNTA Earnings ARQT Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of Earnings This page (NASDAQ:TBPH) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredYou’re About to Lose Everything – Act Now or Regret It ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBPH Stock Free TBPH Stock Alerts